Y-mAbs Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
230 Park Avenue, Suite 3350, New York, NY
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
9/4/2024, 01:25 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report SC 13G Apr 8, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report SC 13G/A Feb 13, 2024
SC 13G/A Report Y-MABS THERAPEUTICS, INC. Feb 6, 2024
SC 13G/A Report Jan 26, 2024
SC 13G Report Y-MABS THERAPEUTICS, INC. Apr 3, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G Report SC 13G Feb 14, 2023
SC 13G Report SCHEDULE 13G Feb 9, 2023
SC 13G/A Report Feb 1, 2023
SC 13G/A Report SEC SCHEDULE 13G Apr 11, 2022
SC 13G/A Report SC 13G/A Feb 7, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2022
SC 13G/A Report Feb 3, 2022
SC 13G/A Report SEC SCHEDULE 13G Jul 12, 2021
SC 13G/A Report SC 13G/A Feb 12, 2021
SC 13G/A Report SEC SCHEDULE 13G Feb 4, 2021
SC 13G Report Feb 2, 2021
SC 13G/A Report SC 13G/A Aug 27, 2020
SC 13G Report SC 13G Aug 26, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report SC 13G/A Feb 11, 2020
SC 13G/A Report Feb 10, 2020
SC 13G Report Feb 7, 2020
SC 13G Report SEC SCHEDULE 13G Jan 28, 2020
SC 13G/A Report SC 13G/A Feb 14, 2019
SC 13G Report SCHEDULE 13G Nov 7, 2018
SC 13G Report SC 13G Oct 1, 2018